Min Luo

9.0k citations
206 papers · 4.9k indexed · 2 hit papers · h-index 36

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • RNA Interference and Gene Delivery
    • Circular RNAs in diseases
    • RNA modifications and cancer

Papers in

Min Luo

190 papers receiving 4.8k citations

Hit Papers

The Hippo signalling pathway and its implications in human health and diseases 2022 · 358 citations
3582021202620222024100200300

Peers

Min Luo
Comparison fields: 5 of 151
  • Cancer Research 663
  • Molecular Biology 2.3k
  • Immunology 665
  • Oncology 706
  • Cell Biology 402
Replace Harsha Gowda with:
Harsha Gowda India
Michael A. McNutt China
Xiao‐Fan Wang China
Ping Qiu United States
Alejandro Zentella‐Dehesa Mexico
Mamoru Satoh Japan
Xiao‐Ming Yin United States
Takashi Kojima Japan
David J. Granville Canada
Jinhua Zhang China
Min Luo relative to Harsha Gowda India Harsha Gowda's profile →
Citations per field
00.5×1.5×1.9×
Harsha Gowda · 1×
Citations per year

Countries citing papers authored by Min Luo

Since Specialization
Citations

This map shows the geographic impact of Min Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Luo more than expected).

Fields of papers citing papers by Min Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Luo. The network helps show where Min Luo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Min Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Min Luo Line = papers co-authored together Min Luo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20250
3 20251
4 20250
5 20242
6 20243
7 20240
8 202314
9 20232
10 202239
11 202212
12 202222
13 202220
14 20202
15 202069
16 2014118
17 20138
18
Long-Term Regulation of Lipolysis by Insulin in Human Adipocytes
20051
19
Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
200533
20 20056

About Min Luo

Min Luo is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 206 papers that have together received 4.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), RNA Interference and Gene Delivery (10 papers), Thyroid Disorders and Treatments (8 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Cancer Research (663 citations), Molecular Biology (2.3k citations), Immunology (665 citations), Oncology (706 citations) and Cell Biology (402 citations). Min Luo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiawei Wei, Tianxia Lan, Yuan Hu, Minyang Fu, Kun‐Liang Guan, Yuquan Wei, Ting Luo, Katherine A. Hajjar, Zhiyao He and Bin Shao. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications, Frontiers in Oncology, Oncology Reports and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026